Research Roundup

Debbie Rigby rounds up the latest in research news Dual bronchodilation for the treatment of COPD Dual bronchodilation with long-acting muscarinic receptor antagonists (LAMAs) and long-acting β-agonists (LABAs) fixed dose combinations are more effective than monotherapy for the treatment of patients with COPD. All LAMA/LABA FDCs are consistently more effective than LAMA or LABA administered

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Changing practice
Next States line up for free flu jabs